Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy
DBV Technologies
Matthew Greenhawt; Sayantani B Sindher; Julie Wang; Michael O'Sullivan; George du Toit; Edwin H Kim; Deborah Albright; Sara Anvari; Nicolette Arends; Peter D Arkwright; Philippe Bégin; Katharina Blumchen; Thierry Bourrier; Terri Brown-Whitehorn; Heather Cassell; Edmond S Chan; Christina E Ciaccio; Antoine Deschildre; Amandine Divaret-Chauveau; Stacy L Dorris; Morna J Dorsey; Thomas Eiwegger; Michel Erlewyn-Lajeunesse; David M Fleischer; Lara S Ford; Maria Garcia-Lloret; Lisa Giovannini-Chami; Jonathan O Hourihane; Nicola Jay; Stacie M Jones; Leigh Ann Kerns; Kirsten M Kloepfer; Stephanie Leonard; Guillaume Lezmi; Jay A Lieberman; Jeanne Lomas; Melanie Makhija; Christopher Parrish; Jane Peake; Kirsten P Perrett; Daniel Petroni; Wolfgang Pfützner; Jacqueline A Pongracic; Patrick Quinn; Rachel G Robison; Georgiana Sanders; Lynda Schneider; Hemant P Sharma; Juan Trujillo; Paul J Turner; Katherine Tuttle; Julia E Upton; Pooja Varshney; Brian P Vickery; Christian Vogelberg; Brynn Wainstein; Robert A Wood; Katharine J Bee; Dianne E Campbell; Todd D Green; Rihab Rouissi; Aurélie Peillon; Henry T Bahnson; Timothée Bois; Hugh A Sampson; A Wesley Burks